Health & Fitness
Mon, March 5, 2012
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ Ironwood Pharmaceuticals, Inc. ] (NASDAQ: IRWD) will present at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5, 2012 at 4:10 p.m. Eastern Time at the Marriott Copley Place in Boston.
A live webcast of Ironwoodas presentation will be accessible through the Investors section of Ironwoodas website at [ www.ironwoodpharma.com ]. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwoodas website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwoodas GC-C agonist, is an investigational drug for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The efficacy portion of linaclotideas development program has been completed and supports the recently submitted NDA for both indications, as well as the MAA submission in Europe for the IBS-C indication. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass. To learn more, visit [ www.ironwoodpharma.com ].
